Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis, BMC Cancer, vol.28, issue.4, p.890, 2015. ,
DOI : 10.1200/JCO.2009.26.8847
Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis, JNCI Journal of the National Cancer Institute, vol.102, issue.9, pp.627-664, 2010. ,
DOI : 10.1093/jnci/djq101
Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy, Breast Cancer Research and Treatment, vol.302, issue.151, pp.351-61, 2016. ,
DOI : 10.1001/jama.2009.1498
The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study, Annals of Surgical Oncology, vol.72, issue.12, pp.3853-60, 2015. ,
DOI : 10.1158/0008-5472.CAN-12-0636
Breast ductal carcinoma in situ with microinvasion, Cancer, vol.7, issue.8, pp.2134-2176, 2002. ,
DOI : 10.1097/00125480-200007020-00005
The locoregional recurrence post-mastectomy for ductal carcinoma in situ: Incidence and risk factors, The Breast, vol.24, issue.5, pp.608-620, 2015. ,
DOI : 10.1016/j.breast.2015.06.005
URL : https://hal.archives-ouvertes.fr/hal-01187429
Analyzing the Risk of Recurrence after Mastectomy for DCIS: A New Use for the USC/Van Nuys Prognostic Index, Annals of Surgical Oncology, vol.72, issue.24, pp.459-62, 2011. ,
DOI : 10.1016/j.ijrobp.2008.06.482
Outcomes in Patients Treated With Mastectomy for Ductal Carcinoma In Situ, International Journal of Radiation Oncology*Biology*Physics, vol.85, issue.3, pp.129-134, 2013. ,
DOI : 10.1016/j.ijrobp.2012.10.020
Metastatic Invasive Breast Cancer Recurrence Following Curative-Intent Therapy for Ductal Carcinoma In Situ, Journal of Surgical Research, vol.173, issue.1, pp.10-15, 2012. ,
DOI : 10.1016/j.jss.2011.04.058
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ, JAMA Oncology, vol.1, issue.7, pp.888-96, 2015. ,
DOI : 10.1001/jamaoncol.2015.2510
Mortality Among Women With Ductal Carcinoma In Situ of the Breast in the Population-Based Surveillance, Epidemiology and End Results Program, Archives of Internal Medicine, vol.160, issue.7, pp.953-961, 2000. ,
DOI : 10.1001/archinte.160.7.953
Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial, Journal of Clinical Oncology, vol.31, issue.32, pp.4054-4063, 2013. ,
DOI : 10.1200/JCO.2013.49.5077
Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS, JNCI Journal of the National Cancer Institute, vol.103, issue.6, pp.478-88, 2011. ,
DOI : 10.1093/jnci/djr027
Biologic behavior and long-term outcomes of breast ductal carcinoma <i>in situ</i> with microinvasion, Oncotarget, vol.7, issue.39, pp.64182-90, 2016. ,
DOI : 10.18632/oncotarget.11639
Microinvasive ductal carcinoma in situ: Clinical presentation, imaging features, pathologic findings, and outcome, European Journal of Radiology, vol.73, issue.1, pp.102-109, 2010. ,
DOI : 10.1016/j.ejrad.2008.09.037
Ductal Carcinoma in Situ at Core-Needle Biopsy: Meta-Analysis of Underestimation and Predictors of Invasive Breast Cancer, Radiology, vol.260, issue.1, pp.119-147, 2011. ,
DOI : 10.1148/radiol.11102368
Underestimation of malignancy of breast coreneedle biopsy: concepts and precise overall and category-specific estimates, Cancer. 1 févr, vol.109, issue.3, pp.487-95, 2007. ,
Determinants of Patients? Choice of Reconstruction with Mastectomy for Primary Breast Cancer, Annals of Surgical Oncology, vol.20, issue.8, pp.762-71, 2004. ,
DOI : 10.1245/ASO.2004.11.027
Breast reconstruction after mastectomy: A ten-year analysis of trends and immediate postoperative outcomes, The Breast, vol.32, pp.7-12, 2017. ,
DOI : 10.1016/j.breast.2016.11.023
Disparities in Reconstruction Rates after Mastectomy for Ductal Carcinoma in Situ (DCIS): Patterns of Care and Factors Associated with the Use of Breast Reconstruction for DCIS Compared with Invasive Cancer, Annals of Surgical Oncology, vol.3, issue.11, pp.3210-3219, 2011. ,
DOI : 10.1007/BF02305667
Patient age and breast resection weight affect immediate postmastectomy breast reconstruction in ductal carcinoma in situ, Journal of Plastic, Reconstructive & Aesthetic Surgery, vol.69, issue.1, pp.37-41, 2016. ,
DOI : 10.1016/j.bjps.2015.09.023
URL : https://hal.archives-ouvertes.fr/hal-01577018
Factors influencing the decision to offer immediate breast reconstruction after mastectomy for ductal carcinoma in situ (DCIS): The Institut Gustave Roussy Breast Cancer Study Group experience, The Breast, vol.22, issue.5, pp.673-678, 2013. ,
DOI : 10.1016/j.breast.2013.01.002
The Psychological Impact of Immediate Breast Reconstruction for Women with Early Breast Cancer, Plastic and Reconstructive Surgery, vol.73, issue.4, pp.619-647, 1984. ,
DOI : 10.1097/00006534-198404000-00018
Different Distribution of Breast Cancer Subtypes in Breast Ductal Carcinoma in situ (DCIS), DCIS with Microinvasion, and DCIS with Invasion Component, Annals of Surgical Oncology, vol.15, issue.5, pp.1342-1350, 2011. ,
DOI : 10.1097/01.MP.0000038462.62634.B1
Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer, World J Surg Oncol, vol.10, p.262, 2012. ,
Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0), Cancer. 1 déc, vol.76, issue.11, pp.2266-74, 1995. ,
Intra-operative evaluation of the sentinel lymph node for T1-N0 breast-cancer patients: Always or never? A risk/benefit and cost/benefit analysis, European Journal of Surgical Oncology (EJSO), vol.36, issue.8, pp.737-781, 2010. ,
DOI : 10.1016/j.ejso.2010.06.010
URL : https://hal.archives-ouvertes.fr/hal-00608926
Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study, Annals of Oncology, vol.25, issue.3, pp.623-631, 2014. ,
DOI : 10.1093/annonc/mdt532
Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival, The Breast, vol.23, issue.4, pp.346-51, 2014. ,
DOI : 10.1016/j.breast.2014.01.015
Presence of ductal carcinoma in situ confers an improved prognosis for patients with T1N0M0 invasive breast carcinoma, Brazilian Journal of Medical and Biological Research, vol.28, issue.8, pp.913-922, 2002. ,
DOI : 10.1016/S0959-8049(05)80117-0
Impact of the presence and quantity of ductal carcinoma in situ component on the outcome of invasive breast cancer, Int J Clin Exp Pathol, vol.8, issue.10, pp.13304-13317, 2015. ,
Breast ductal carcinoma in situ: a literature review of adjuvant hormonal therapy, Oncology Reviews, vol.10, issue.2, p.304, 2016. ,
DOI : 10.4081/oncol.2016.304
Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience, Seminars in Oncology, vol.28, issue.4, pp.400-418, 2001. ,
DOI : 10.1016/S0093-7754(01)90133-2
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial, The Lancet Oncology, vol.12, issue.1, pp.21-30, 2011. ,
DOI : 10.1016/S1470-2045(10)70266-7
Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study, Breast Cancer Research and Treatment, vol.2010, issue.41, pp.145-54, 2013. ,
DOI : 10.1093/jncimonographs/lgq029
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial, The Lancet, vol.383, issue.9922, pp.1041-1049, 2014. ,
DOI : 10.1016/S0140-6736(13)62292-8
Exemestane for Breast-Cancer Prevention in Postmenopausal Women, New England Journal of Medicine, vol.364, issue.25, pp.2381-91, 2011. ,
DOI : 10.1056/NEJMoa1103507
Prediction of margin involvement and local recurrence after skin-sparing and simple mastectomy, European Journal of Surgical Oncology (EJSO), vol.42, issue.7, pp.935-976, 2016. ,
DOI : 10.1016/j.ejso.2016.04.055
Is there a role for postmastectomy radiation therapy in ductal carcinoma in situ, Int J Surg Oncol, vol.2012, p.423520, 2012. ,
Is Radiation Indicated in Patients With Ductal Carcinoma In Situ and Close or Positive Mastectomy Margins?, International Journal of Radiation Oncology*Biology*Physics, vol.80, issue.1, pp.25-30, 2011. ,
DOI : 10.1016/j.ijrobp.2010.01.044
Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.4, pp.1016-1036, 2008. ,
DOI : 10.1016/j.ijrobp.2008.06.1954
Molecular phenotypes of DCIS predict overall and invasive recurrence, Annals of Oncology, vol.26, issue.5, pp.1019-1044, 2015. ,
DOI : 10.1093/annonc/mdv062
Radiotherapy for invasive breast cancer: Guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence, Critical Reviews in Oncology/Hematology, vol.79, issue.2, pp.91-102, 2011. ,
DOI : 10.1016/j.critrevonc.2010.06.002
Adjuvant radiotherapy after mastectomy for pT1???pT2 node negative (pN0) breast cancer: is it worth the effort?, Radiotherapy and Oncology, vol.68, issue.3, pp.227-258, 2003. ,
DOI : 10.1016/S0167-8140(03)00234-2
Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: A systematic review, Radiotherapy and Oncology, vol.91, issue.1, pp.23-32, 2009. ,
DOI : 10.1016/j.radonc.2008.09.026
Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.5, pp.1337-1384, 2005. ,
DOI : 10.1016/j.ijrobp.2004.08.009
Comparison of Clinical Outcome of Breast Cancer Patients with T1-2 Tumor and One to Three Positive Nodes with or without Postmastectomy Radiation Therapy, Japanese Journal of Clinical Oncology, vol.42, issue.8, pp.711-731, 2012. ,
DOI : 10.1093/jjco/hys080
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update, Practical Radiation Oncology, vol.6, issue.6, pp.219-253, 2016. ,
DOI : 10.1016/j.prro.2016.08.009
Do T1a breast cancers profit from adjuvant systemic therapy? A multicenter retrospective cohort study of 325 ,
Ductal Carcinoma In Situ of the Breast: Influence of Age on Diagnostic, Therapeutic, and Prognostic Features. Retrospective Study of 812 Patients, Annals of Surgical Oncology, vol.48, issue.5, pp.1372-1381, 2011. ,
DOI : 10.1016/S0360-3016(00)00715-X
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women, Breast Cancer Research and Treatment, vol.51, issue.32, pp.553-63, 2016. ,
DOI : 10.1016/j.ejca.2015.05.008
Clinicopathologic characteristics and molecular subtypes of microinvasive carcinoma of the breast, Tumor Biology, vol.23, issue.4, pp.2241-2249, 2015. ,
DOI : 10.1200/JCO.2005.08.001
Risk Factors for Locoregional Recurrence After Mastectomy in Stage T1 N0 Breast Cancer, American Journal of Clinical Oncology, vol.37, issue.5, pp.486-91, 2014. ,
DOI : 10.1097/COC.0b013e31827e54c2
Role of post mastectomy radiation therapy in breast cancer patients with T1–2 and 1–3 positive lymph nodes, OncoTargets and Therapy, vol.9, pp.5587-95, 2016. ,
DOI : 10.2147/OTT.S106871
Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ, Applied Immunohistochemistry & Molecular Morphology, vol.24, issue.1, pp.20-25, 2016. ,
DOI : 10.1097/PAI.0000000000000223
Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review, Journal of Cancer, vol.2, pp.232-61, 2011. ,
DOI : 10.7150/jca.2.232
Hormonal receptor status, Ki-67 and HER2 expression: Prognostic value in the recurrence of ductal carcinoma in situ of the breast?, The Breast, vol.25, pp.57-61, 2016. ,
DOI : 10.1016/j.breast.2015.10.007
Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence, Clinical Oncology, vol.24, issue.3, pp.183-192, 2012. ,
DOI : 10.1016/j.clon.2011.09.008
Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone, Cancer, vol.67, issue.16, pp.3650-3657, 2011. ,
DOI : 10.1158/0008-5472.CAN-06-4038
Abrogated Response to Cellular Stress Identifies DCIS Associated with Subsequent Tumor Events and Defines Basal-like Breast Tumors, Cancer Cell, vol.12, issue.5, pp.479-91, 2007. ,
DOI : 10.1016/j.ccr.2007.10.017
Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence, British Journal of Cancer, vol.89, issue.10, pp.1920-1926, 2003. ,
DOI : 10.1038/sj.bjc.6601398
Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora???s box, Cancer Treatment Reviews, vol.55, pp.1-9, 2017. ,
DOI : 10.1016/j.ctrv.2017.01.010
Impact of Margin Status on Local Recurrence After Mastectomy for Ductal Carcinoma In Situ, 948?52. REFERENCES 1. Seradour B. Breast cancer screening in France: an overview, pp.191-200, 2009. ,
DOI : 10.1016/j.ijrobp.2012.07.2377
Trends in the Treatment of Ductal Carcinoma In Situ of the Breast, JNCI Journal of the National Cancer Institute, vol.96, issue.6, pp.443-451, 2004. ,
DOI : 10.1093/jnci/djh069
Sentinel Node Biopsy is Important in Mastectomy for Ductal Carcinoma In Situ, Annals of Surgical Oncology, vol.10, issue.1 ,
DOI : 10.1245/s10434-007-9610-6
National Institutes of Health State-of-the-Science Conference Statement: diagnosis and management of ductal carcinoma in situ, 2009. ,
Clinical applications of breast pathology: management of in situ breast carcinomas and sentinel node biopsy issues, Modern Pathology, vol.14, pp.33-38, 2010. ,
DOI : 10.1245/ASO.2005.05.004
Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial, JNCI: Journal of the National Cancer Institute, vol.98, issue.9, pp.599-609, 2006. ,
DOI : 10.1093/jnci/djj158
Sentinel Lymph Node Biopsy in Breast Cancer, Annals of Surgery, vol.251, issue.4, pp.595-600, 2010. ,
DOI : 10.1097/SLA.0b013e3181c0e92a
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis, JAMA, vol.305, issue.6, pp.569-75, 2011. ,
DOI : 10.1001/jama.2011.90
Prospective Multicentric Randomized Study Comparing Periareolar and Peritumoral Injection of Radiotracer and Blue Dye for the Detection of Sentinel Lymph Node in Breast Sparing Procedures: FRANSENODE Trial, Journal of Clinical Oncology, vol.25, issue.24, pp.3664-3673, 2007. ,
DOI : 10.1200/JCO.2006.08.4228
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer, Journal of Clinical Oncology, vol.25, issue.1, pp.118-163, 2007. ,
DOI : 10.1200/JCO.2006.09.2775
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in ?pure? ductal carcinoma in situ of the breast, Histopathology, vol.10, issue.2, pp.227-265, 2007. ,
DOI : 10.1038/nrc1251
Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis, JNCI Journal of the National Cancer Institute, vol.102, issue.9, pp.627-664, 2010. ,
DOI : 10.1093/jnci/djq101
Guidelines for Sentinel Node Biopsy and Lymphatic Mapping of Patients With Breast Cancer, Annals of Surgery, vol.227, issue.5 ,
DOI : 10.1097/00000658-199805000-00005
Ductal Carcinoma in Situ at Core-Needle Biopsy: Meta-Analysis of Underestimation and Predictors of Invasive Breast Cancer, Radiology, vol.260, issue.1, pp.119-147, 2011. ,
DOI : 10.1148/radiol.11102368
Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ, Cancer, vol.50, issue.8, pp.1760-1768, 2006. ,
DOI : 10.1016/S0039-6109(16)45185-6
Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ, Journal of the American College of Surgeons, vol.200, issue.4, pp.516-542, 2005. ,
DOI : 10.1016/j.jamcollsurg.2004.11.012
Predictors of Invasion and Axillary Lymph Node Metastasis in Patients with a Core Biopsy Diagnosis of Ductal Carcinoma In Situ: An Analysis of 255 Cases, The Breast Journal, vol.6, issue.3, pp.223-232, 2011. ,
DOI : 10.1046/j.1524-4741.2000.20002.x
Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision, The Breast, vol.21, issue.5, pp.641-646, 2012. ,
DOI : 10.1016/j.breast.2012.06.012
Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients, The American Journal of Surgery, vol.194, issue.2, pp.172-177, 2007. ,
DOI : 10.1016/j.amjsurg.2006.11.027
Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: Experience of 733 cases, The Breast, vol.21, issue.5, pp.635-675, 2012. ,
DOI : 10.1016/j.breast.2012.06.009
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23???01): a phase 3 randomised controlled trial, The Lancet Oncology, vol.14, issue.4, pp.297-305, 2013. ,
DOI : 10.1016/S1470-2045(13)70035-4
Tumour-positive sentinel node findings in patients with ductal carcinoma in situ, Journal of Surgical Oncology, vol.12, issue.5, pp.380-384, 2006. ,
DOI : 10.1002/jso.20581
What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?, The American Journal of Surgery, vol.192, issue.4, pp.455-462, 2006. ,
DOI : 10.1016/j.amjsurg.2006.06.028
Outcome of Patients with Ductal Carcinoma In Situ and Sentinel Node Biopsy, Annals of Surgical Oncology, vol.207, issue.7 ,
DOI : 10.1016/j.jamcollsurg.2008.06.139
Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer, World Journal of Surgical Oncology, vol.8, issue.1, pp.319-344, 2010. ,
DOI : 10.1186/1477-7819-8-6
Sentinel Node Procedure is Warranted in Ductal Carcinoma In Situ with High Risk of Occult Invasive Carcinoma and Microinvasive Carcinoma Treated by Mastectomy, The Breast Journal, vol.55, issue.2, pp.135-175, 2008. ,
DOI : 10.1200/JCO.2005.03.3225
Micrometastases in Sentinel Lymph Node in a Multicentric Study: Predictive Factors of Nonsentinel Lymph Node Involvement???Groupe Des Chirurgiens De La Federation Des Centres De Lutte Contre Le Cancer, Journal of Clinical Oncology, vol.24, issue.12, pp.1814-1822, 2006. ,
DOI : 10.1200/JCO.2005.03.3225
Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer, The American Journal of Surgery, vol.196, issue.1, pp.81-88, 2008. ,
DOI : 10.1016/j.amjsurg.2007.08.057
Predictive factors for breast cancer in patients diagnosed with ductal intraepithelial neoplasia, grade 1B, Anticancer Res, vol.32, pp.3571-3580, 2012. ,
Accuracy of a Preoperative Model for Predicting Invasive Breast Cancer in Women with Ductal Carcinoma-in-situ on Vacuum-Assisted Core Needle Biopsy, Annals of Surgical Oncology, vol.8, issue.5, pp.1364-71, 2011. ,
DOI : 10.1016/S1470-2045(07)70278-4
What is the predictor for invasion in nonpalpable breast cancer with microcalcifications? Breast Cancer, pp.49-54, 2004. ,
8- or 11-gauge vacuum-assisted biopsy, The British Journal of Radiology, vol.85, issue.1016, pp.349-56, 2012. ,
DOI : 10.1259/bjr/30974918
Role of Sentinel Lymph Node Biopsy in Ductal Carcinoma-in-situ Treated by Mastectomy, Annals of Surgical Oncology, vol.98, issue.2, pp.638-683, 2007. ,
DOI : 10.1038/bjc.1992.230
Predictors of Treatment with Mastectomy, Use of Sentinel Lymph Node Biopsy and Upstaging to Invasive Cancer in Patients Diagnosed with Breast Ductal Carcinoma In situ (DCIS) on Core Biopsy, Annals of Surgical Oncology, vol.345, issue.165, pp.66-73, 2014. ,
DOI : 10.1136/bmj.e4505
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer, Human Pathology, vol.23, issue.9, pp.974-983, 1992. ,
DOI : 10.1016/0046-8177(92)90257-4
Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast, Clinics, vol.68, issue.5, pp.674-682, 2013. ,
DOI : 10.6061/clinics/2013(05)15
Underestimation of invasive lesions in patients with ductal carcinoma in situ of the breast diagnosed by ultrasound-guided biopsy: A comparison between patients with and without HER2/neu overexpression, European Journal of Radiology, vol.83, issue.6, pp.935-976, 2014. ,
DOI : 10.1016/j.ejrad.2014.02.020
Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup, Oncotarget, vol.4, issue.2, pp.231-272, 2013. ,
DOI : 10.18632/oncotarget.818
Correlation of HER2 Gene Amplification With Expression of the Apoptosis-Suppressing Genes bcl-2 and bcl-x-L in Ductal Carcinoma in Situ of the Breast, Applied Immunohistochemistry & Molecular Morphology, vol.13, issue.1, pp.14-22, 2005. ,
DOI : 10.1097/00129039-200503000-00003
Differentially Expressed Genes Regulating the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer, Cancer Research, vol.72, issue.17, pp.4574-86, 2012. ,
DOI : 10.1158/0008-5472.CAN-12-0636